Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of DDC polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Bovine,Dog,Guinea pig,Human,Rabbit,Rat,Sheep |
| Host species | Rabbit |
| Applications | WB-Ti |
More info about DDC polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB9598 |
| Product name: | DDC polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of DDC. |
| Gene id: | 1644 |
| Gene name: | DDC |
| Gene alias: | AADC |
| Gene description: | dopa decarboxylase (aromatic L-amino acid decarboxylase) |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus human DDC. |
| Protein accession: | P20711 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 10 mM HEPES, 150 mM NaCl, pH 7.5 (50% glycerol, 10% BSA) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Bovine,Dog,Guinea pig,Human,Rabbit,Rat,Sheep |
| Application image: |  |
| Application image note: | Western blot of 5 ug of bovine adrenal medulla lysate showing specific immunolabeling of the ~55k DDC protein. Using DDC polyclonal antibody (Cat # PAB9598). |
| Applications: | WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Striatal dopaminergic and serotonergic markers in human heroin users.Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Neuropsychopharmacology. 2001 May;24(5):561-7. |